Avicanna
Toronto
About Avicanna
Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space. It provides the global marketplace with advanced natural cannabinoid solutions through an evidence-based approach offered across several product platforms, including API, medical, pharmaceutical, and derma cosmetics. As a multinational organization with vertical integration, Avicanna is focused on utilizing the scientific research related to plant-derived cannabinoid products through its internal research platforms and strategic collaborations with world-class research institutions. Avicanna was founded in 2016 and is headquartered in Toronto, Ontario, Canada.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $51.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: tsx:AVCN
- Website: avicanna.com
- Phone: 1(647)243-5283
Industries & Categories
Biotechnology, Cannabis, Clinical Trials, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/avicanna-52201 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.